Risk factors for invasive mold infection after COVID-19: case-control study
African Health Sciences · 2025
DOI: 10.4314/ahs.v24i4.10 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift African Health Sciences, 2025. Verfasst von Esma Eryilmaz-Eren und 10 weiteren Autor:innen. Beteiligte Einrichtung: Kayseri City Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Kayseri, Turkey. Hauptthemen laut MEDLINE: COVID-19, Invasive Fungal Infections, Mucormycosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Invasive mold infections (IMI) have become common in patients with severe COVID-19 pneumonia, which are difficult to diagnose and treat, with a high mortality rate.
Objective
The aim of this study was to determine risk factors for invasive mold infections associated with COVID-19.
Methods
In this prospective, case-control study, patients treated for severe COVID-19 pneumonia in intensive care units with invasive mold infection were compared with severe COVID-19 pneumonia patients with no secondary infection (bacterial or fungal). Demographics, treatments received and outcomes were compared.
Results
Twenty patients were included in the IMI group and 19 patients in the control group. Invasive aspergillosis was observed in 13 patients (65.0%) while mucormycosis was observed in seven patients (35.0%). Demographics and clinical characteristics were similar between IMI and control group (p>0.005). The 28-day mortality was 60.0% in the IMI group and 15.8% in the control group (p=0.005). The use of steroids has been identified as the most important risk factor for developing IMI (90.0% vs. 15.8%, OR: 25.712, p=0.009).
Conclusion
Rationale use of steroids, with appropriate indication, dose and duration is important in the treatment of severe COVID-19 pneumonia. Keywords: Invasive mold infections; COVID-19; mucormycosis; invasive fungal sinusitis; invasive pulmonary aspergillosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kayseri City Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Kayseri, Turkey.
- Kayseri City Training and Research Hospital, Department of Medical Mycology, Kayseri, Turkey.
- Kayseri City Training and Research Hospital, Department of Intensive Care, Kayseri, Turkey.
- Kayseri City Training and Research Hospital, Department of Otorhinolaryngology-Head and Neck Surgery, Kayseri, Turkey.
- Kayseri City Training and Research Hospital, Department of Infectious Disease and Clinical Microbiology, Kayseri, Turkey.
- University of Health Sciences, Kayseri City Education and Research Hospital, Department of Infectious Disease and Clinical Microbiology, Kayseri, Turkey.
Zitieren
APA
Eryilmaz-Eren, E., Sav, H., Ozer-Simsek, Z., Ozcan, İ., Kilinc-Toker, A., Kanat, A., Cetinkaya, A., Yuksel, R. C., Aydin, K., Guzeldag, S., & Celik, I. (2025). Risk factors for invasive mold infection after COVID-19: case-control study. African Health Sciences. https://doi.org/10.4314/ahs.v24i4.10
Vancouver
Eryilmaz-Eren E, Sav H, Ozer-Simsek Z, Ozcan İ, Kilinc-Toker A, Kanat A, et al. Risk factors for invasive mold infection after COVID-19: case-control study. African Health Sciences. 2025. doi:10.4314/ahs.v24i4.10
BibTeX
@article{EryilmazEren2025,
author = {Eryilmaz-Eren, Esma and Sav, Hafize and Ozer-Simsek, Zuhal and Ozcan, İbrahim and Kilinc-Toker, Aysin and Kanat, Azade and Cetinkaya, Ali and Yuksel, Recep Civan and Aydin, Kaniye and Guzeldag, Seda and Celik, Ilhami},
title = {Risk factors for invasive mold infection after COVID-19: case-control study},
journal = {African Health Sciences},
year = {2025},
doi = {10.4314/ahs.v24i4.10}
}
EUVIMED